The New York Entrepreneur

More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study

Read Time:7 Second

Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Ford, UAW negotiators reach labor deal, pending union leadership approval
Next post Mattel says Barbie sales grew 16% as blockbuster movie became a phenomenon